Illinois

Showing 11-15 of 15 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Development of β-Cell Targeted Lipid Nanoparticle Therapeutics	The University of Chicago	Jacob Ryan Enriquez	Cures	01-March-2025 to 29-February-2028	$247,790.00
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation	The University of Chicago	Piotr Witkowski	Cures	01-February-2024 to 31-January-2026	$250,000.00
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation	The University of Chicago	Piotr Witkowski	Cures	01-February-2025 to 31-January-2027	$1,000,000.00
Safety and efficacy assessment of Tegoprubart and calcineurin inhibitors- free immunosuppression therapy for pancreatic islet transplantation in patients with t1DM and chronic kidney disease.	The University of Chicago	Piotr Witkowski	Cures	01-September-2025 to 31-August-2029	$8,500,000.00
Engineered Nanoparticles for Beta Cell-Targeted Therapeutics	The University of Chicago	Raghavendra Mirmira	Cures	01-April-2023 to 31-March-2026	$897,822.00